Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 1Kidney Neoplasms 1Kidney Failure, Chronic 1Carcinoma, Renal Cell 1

Interventions

cabozantinib 4Nivolumab 2Ipilimumab 2zimberelimab 1temsirolimus 1salicylhydroxamic acid 1orellanine 1atezolizumab 1Surveys and Questionnaires 1Ropivacaine 1Pluvicto 1Methods 1Health Promotion 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Erlotinib Hydrochloride 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Dacarbazine 1Counseling 1Blood Component Removal 1Axitinib 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × orellanine × 30 days × Clear all
NCT05287945 2026-05-22

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Oncorena AB

Phase 1/2 Recruiting
75 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡